ClinicalTrials.gg
Not yet recruitingNCT05258019Updated Mar 30, 2023

Site Preservation After Tooth Extraction

An observational study in Osteogenesis Imperfecta, Total Absence of Permanent Teeth and Tooth Socket, sponsored by Nanfang Hospital, Southern Medical University. Not yet recruiting. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-30.

Sponsored by Nanfang Hospital, Southern Medical University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
88
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study is mainly targeted affected teeth which could not be retained, and patients are willing to undergo implant repair at the later stage. After teeth extraction, Geistlich Bio-Oss ® Particles or Bio-Oss ® Collagen are immediately implanted in the teeth extraction socket and covered with Bio-Gide ® collagen membrane for site preservation.Through postoperative follow-up, postoperative clinical and imaging objective indicators, combined with the subjective evaluation of surgeons and patients, and compared with conventional extraction treatment method, the study is aimed to evaluate the effectiveness of different site preservation of alveolar crest preservation, in order to reduce the alveolar bone width and height loss, effectively reduce alveolar bone absorption, or even achieve bone incrementation, thus to get the ideal site preservation effect, to improve the oral implant success rate, improve implant aesthetic score and patient satisfaction, provide more clinical standard reference of the clinical application of site preservation.

02

Conditions studied

  • Osteogenesis Imperfecta
  • Total Absence of Permanent Teeth
  • Tooth Socket
03

In context

Osteogenesis Imperfecta

84 studies on the registry are indexed under Osteogenesis Imperfecta; 20 are open to participants now.

This study's planned enrollment of 88 is above the median of 75 across 23 observational studies indexed under Osteogenesis Imperfecta.

Browse Osteogenesis Imperfecta studies →

Lead sponsor

Nanfang Hospital, Southern Medical University is the lead sponsor of 490 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients who have teeth cannot be retained and are willing to do dental implant treatment at the teeth extration site.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients willing to performed site preservation with Geistlich Bio-Oss ® Particles + Bio-Gide ® collagen membrane after tooth extraction;
  • patients willing to performed site preservation with Geistlich Bio-Oss ® Collagen + Bio-Gide ® collagen membrane after tooth extraction;
  • patients willing to performed no site preservation after tooth extraction and only conventional healing.

Exclusion criteria

Exclusion Criteria:

  • patients unwilling to sign the form and the letter of authorization;
  • patients has a potential systematic diseases;
  • patients had previously been treated with radiation therapy;
  • patients can not re-visit on time.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
88 participants (estimated)
Patient registry
No

Groups and cohorts

  • Geistlich Bio-Oss ® Particles + Bio-Gide ® collagen membrane

    The first group of patients selected for site preservation will be performed with Bio-Oss ® Particles + Bio-Gide ® collagen membrane after tooth extraction

  • Geistlich Bio-Oss ® Collagen + Bio-Gide ® collagen membrane

    The second group of patients selected for site preservation will be performed with Bio-Oss ® Collagen + Bio-Gide ® collagen membrane after tooth extraction

  • Conventional healing after tooth extraction, without site preservation

    The third group of patients selected will be performed without site preservation after tooth extraction, and only conventional healing

06

What researchers measure

Primary outcomes

  1. Changes in the alveolar crest height - central

    The central alveolar bone height of the ideal implant site will be measured with CBCT at 3 months after tooth extraction or plus site preservation

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  2. Changes in the alveolar crest width - central

    The central alveolar bone width of the ideal implant site will be measured with CBCT at 3 months after tooth extraction alone or plus site preservation

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

Secondary outcomes

  1. Changes in the alveolar bone width - different depths

    The width of the alveolar bone at 1,3,5, and 7mm below the alveolar crest will be measured with CBCT at 3 months after tooth extraction or plus site preservation

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  2. Changes in the alveolar bone height - different horizontal sites

    The height of the alveolar bone will be measured at the mesial, central and distal of buccal and lingual of alveolar crest,and the midpoint of the mesial and distal of interproximal sites with CBCT at 3 months after tooth extraction alone or plus site preservation

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  3. Soft tissue thickness

    The thickness of soft tissue will be measured at middle, central, and distal sites of both buccal-lingual sides,3mm from free gingival margin

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  4. Plaque index (PLI)

    Each tooth extraction socket will be measured on 6 sites: buccal, central and lingual of both mesial-distal sides

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  5. Bleeding index (BI)

    Each tooth extraction socket will be measured on 6 sites: buccal, central and lingual of both mesial-distal sides

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  6. Probing depth (PD)

    Each tooth extraction socket will be measured on 6 sites: buccal, central and lingual of both mesial-distal sides

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  7. Phenotype assessment

    Whether thick or thin gingival biotype will be detected by the transparency of the soft tissue while periodontal probing diagnosis

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery

  8. Pain degree

    The Visual Analogue Scale (VAS) pain score was evaluated: 0-10 (0: no pain; 1-3: slightly painful, acceptable; 4-6: painful, disrupt sleep, tolerable; 7-10: very painful, untolerable, affect sleep and diet)

    Time frame: up to 12 weeks after Dental extraction or site preservation surgery.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2023; primary completion for Oct 2026, 35 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 7, 2022
First posted
Feb 28, 2022
StartEst.
Nov 1, 2023
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2027
Last update
Mar 30, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05258019
Responsible party
Sponsor
First posted
Feb 28, 2022
Start date
Nov 1, 2023 (estimated)
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Mar 30, 2023

Study contacts

Qi Liu, Ph.D.
Contact
liuqi0721@smu.edu.cn
+86 20 62787153

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion